The Samuel Singer Lab

[Placeholder Image]

Soft tissue sarcoma is a heterogeneous disease with more than 50 histological subtypes, which have diverse biological behavior and – in many cases – unique genetics. Many sarcoma subtypes respond poorly to chemotherapy, so there is an urgent need for better treatment options for patients whose disease cannot be cured surgically. The major focus of my research is the discovery of genetic and epigenetic alterations in sarcoma to gain insight into sarcoma biology and find new targets for therapy.

Learn more
Pictured: Samuel Singer

Samuel Singer, MD


Research Focus

Physician-scientist Samuel Singer studies the genomic alterations that define new targets for therapy in sarcoma.


MD, Harvard Medical School